or
forgot password

    • cancer clinical trials in cranston, RI

    • Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
    Hematology and Oncology Associates of Rhode Island
    Cranston, Rhode Island 02920
    Breast Cancer
    Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer
    Hematology and Oncology Associates of Rhode Island
    Cranston, Rhode Island 02920
    Esophageal Cancer, Gastric Cancer
    Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
    Hematology and Oncology Associates of Rhode Island Inc
    Cranston, Rhode Island 02920
    Adenocarcinoma of the Colon, Stage III Colon Cancer
    Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
    Sambandam and Joseph Associates, Inc
    Cranston, Rhode Island 02920
    Chronic Lymphocytic Leukemia
    Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
    Hematology and Oncology Associates of Rhode Island Inc
    Cranston, Rhode Island 02920
    Adenocarcinoma of the Colon, Stage II Colon Cancer
    Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
    Hematology and Oncology Associates of Rhode Island Inc
    Cranston, Rhode Island 02920
    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIB Breast Cancer
    Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
    Hematology and Oncology Associates of Rhode Island Inc
    Cranston, Rhode Island 02920
    Clear Cell Renal Cell Carcinoma, Papillary Renal Cell Carcinoma, Stage I Renal Cell Cancer, Stage II Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    Phase III Randomized Study of 5-FU, CoFactor, and Avastin vs. 5-FU, LV and Avastin for First-Line Colorectal Cancer.
    Research Center In
    Cranston, Rhode Island
    Metastatic Colorectal Cancer, Colon Cancer, Rectal Cancer
    GSK1572932A Antigen-Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients With Non-Small Cell Lung Cancer
    GSK Investigational Site
    Cranston, Rhode Island 02920
    Lung Cancer, Non-Small Cell
    Phase 2b Study of Taxol Plus Sorafenib or Placebo in Patients With Advanced Breast Cancer
    Hematology and Oncology Associates of Rhode Island
    Cranston, Rhode Island 02920
    Breast Cancer
    First-Line Chemotherapy and Trastuzumab With or Without Bevacizumab in Treating Patients With Metastatic Breast Cancer That Overexpresses HER-2/NEU
    Hematology and Oncology Associates of Rhode Island Inc
    Cranston, Rhode Island 02920
    HER2-positive Breast Cancer, Male Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer
    Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage III or Stage IV Breast Cancer
    Hematology and Oncology Associates of Rhode Island Inc
    Cranston, Rhode Island 02920
    Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IV Breast Cancer
    Phase II Lapatinib Plus Nab-Paclitaxel As First And Second Line Therapy In her2+ MBC
    GSK Investigational Site
    Cranston, Rhode Island 02920
    Neoplasms, Breast
    BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
    Hematology and Oncology Associates of Rhode Island
    Cranston, Rhode Island 02920
    Renal Cell Carcinoma
    Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
    Hematology & Oncology Associates of Rhode Island
    Cranston, Rhode Island 02920
    Chronic Lymphocytic Leukemia
    Connect® MM- The Multiple Myeloma Disease Registry
    Hematology & Oncology Associates of Rhode Island
    Cranston, Rhode Island 02920
    Multiple Myeloma
    Safety and Efficacy Study for Solid Tumor Patients Treated With Eltrombopag
    GSK Investigational Site
    Cranston, Rhode Island 02920
    Thrombocytopaenia
    Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
    Hematology and Oncology Associates of RI
    Cranston, Rhode Island 02920
    Chronic Myeloid Leukemia
    NP2 Enkephalin For Treatment of Intractable Cancer Pain
    Hematology Oncology Associatesof Rhode Island
    Cranston, Rhode Island 02920
    Intractable Pain, Neoplasms
    A Study to Assess Dolutegravir in HIV-infected Subjects With Treatment Failure on an Integrase Inhibitor Containing Regimen.
    GSK Investigational Site
    Cranston, Rhode Island 02920
    Infection, Human Immunodeficiency Virus
    A Study to Evaluate Tarceva in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
    Drs. Sambandam & Joseph Associates, Inc.
    Cranston, Rhode Island 02920
    Lung Cancer, Non-small-cell Lung Carcinoma
    A Multiple Myeloma Trial in Patients With Bone Metastases
    Hematology & Oncology Associates of RI
    Cranston, Rhode Island 02920
    Multiple Myeloma
    Human Papilloma Virus Vaccine Immunogenicity and Safety Trial in Young Adult Women With GSK Bio's Novel HPV Vaccine.
    GSK Investigational Site
    Cranston, Rhode Island 02920
    Human Papillomavirus (HPV) Infection, Cervical Neoplasia
    Combination Chemotherapy With or Without Bevacizumab in Treating Patients Who Have Had Surgery for Stage II or Stage III Rectal Cancer (Groups I and II Closed to Accrual as of 4/29/2009)
    Hematology and Oncology Associates of Rhode Island Inc
    Cranston, Rhode Island 02920
    Adenocarcinoma of the Rectum, Stage II Rectal Cancer, Stage III Rectal Cancer